PMD - צמיחת הכנסות משנה לשנה ב-12 החודשים האחרונים Psychemedics Inc

Patented hair screening provides Psychemedics (PMD) with a steady stream of revenue, which is reflected in the price action. The year-over-year sales growth rate for the TTM clearly demonstrates the pace of expansion, where the -12.10 metric determines the parameter status. Robotics enhance efficiency by eliminating human error during toxin analysis. However, cannabis legalization and low-cost rapid tests pose threats to the corporate sector's margins.

For Psychemedics, within a mature toxicology examination market, this metric serves as an indicator of expansion efficiency into the school and private testing segments. The annual revenue growth rate for the TTM period is calculated as the percentage change in total income over the last twelve months relative to the same window from the previous year, confirming the business's fundamental stability through the precision of its patented methods.